Brief: Cara Therapeutics Announces Difelikefalin Injection New Drug Application Has Been Submitted In Japan

Tvardi Therapeutics

28/09/2022 12:13

Sept 28 (Reuters) - Cara Therapeutics Inc  CARA.O :
    * CARA THERAPEUTICS ANNOUNCES DIFELIKEFALIN (KORSUVA®)
INJECTION
NEW DRUG APPLICATION HAS BEEN SUBMITTED IN JAPAN
    * CARA THERAPEUTICS - NDA INCLUDES POSITIVE RESULTS OF PHASE
3
STUDY IN JAPAN, JOINTLY CONDUCTED BY MARUISHI AND ITS
SUBLICENSEE KISSEI PHARMACEUTICAL

Source text for Eikon:  ID:nGNX8MrRM1 
Further company coverage:  CARA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))